Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Action immédiate contre l’arthrite réunit 21 organisations, plus de 100 000 patients, des chercheurs, des cliniciens et des défenseurs de la cause afin de transformer la recherche sur l’arthrite et...
-
Arthritis Action Now unites 21 organizations, more than 100,000 patients, researchers, clinicians and advocates to transform arthritis research and care in Canada TORONTO, April 08, 2026 (GLOBE...
-
SAN FRANCISCO, April 08, 2026 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of...
-
Marvel announces financial and strategic backing from 5 Horizons Ventures to support its upcoming Phase 1 clinical trial of patented lead asset MB-204
-
SAN FRANCISCO, April 01, 2026 (GLOBE NEWSWIRE) -- Girard Sharp LLP, a national investment, securities, and consumer class action firm, is investigating potential securities claims on behalf of...
-
Gigamon is recognized as the leading vendor in the deep observability market with 51 percent market share in 2025 by 650 Group.
-
New research from Momentive Software finds growth path visibility and technology efficiency are critical to workforce stability in mission-driven sector.
-
Marvel Biosciences secures $600,000 in non-dilutive funding from Alberta Innovates to support Phase I clinical trials of its autism-focused patented MB-204
-
NEW YORK, March 28, 2026 (GLOBE NEWSWIRE) -- Cointelegraph Research has released a new analysis examining how the United Nations Development Programme (UNDP) is testing blockchain technology to...
-
Nonpartisan research firm provides data for ABC News, CNN, The Associated Press, and other major networks